Non-routine Use of Antibiotics (Amoxi-light)
Operational Experience With Non-routine Use of Antibiotics in the Treatment of Severe Uncomplicated Acute Malnutrition in Children
1 other identifier
observational
2,876
0 countries
N/A
Brief Summary
To evaluate, in routine operational settings of treatment of uncomplicated Severe Acute Malnutrition (SAM) in children aged 6-59 months, the risk of nutritional recovery and hospitalization with non-routine use of amoxicillin compared to the risk achieved with systematic use of antibiotics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2016
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 29, 2017
CompletedFirst Submitted
Initial submission to the registry
November 21, 2017
CompletedFirst Posted
Study publicly available on registry
December 12, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2018
CompletedAugust 14, 2019
August 1, 2019
1.1 years
November 21, 2017
August 13, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluation of nutritional recovery
Primary outcome will be measured in the field of nutrition, hospitalization, death and abandonment in the observation site (s) with that observed in 3 comparison groups: 1. Children receiving amoxicillin and placebo in the randomized trial conducted by MSF (2012-2014) 2. Children receiving amoxicillin in MSF program sites not selected for study in Madarounfa (2016) 3. Children receiving amoxicillin at selected sites from the previous year (2015)
Through study participation, no more than 2 months after follow-up of the last participant
Interventions
All children will receive nutritional treatment and standard medical care in accordance with the nutritional guidelines of the national protocol, with the exception of the routine distribution of antibiotics.
Eligibility Criteria
All children from 6 to 59 months admitted directly for the treatment of uncomplicated SAM(MUAC \<115 mm or PTZ \<-3 and / or presence of nutritional edema grade + or + + and moderate or good appetite with no medical complications) in the 2 CRENAS chosen as study sites during the inclusion period of the study. A "direct admission" is defined as an admission without reference from CRENI (intensive nutritional recovery and education centres) to CRENAS. Readmission cases, that is, children admitted to the nutritional program in the last 3 months, and references from the Center for Ambulatory Nutritional Recovery for Moderates (CRENAM) remain eligible for inclusion of the study without prejudice and without notation at the previous admission.
You may qualify if:
- Age 6-59 months
- Direct admission for the treatment of uncomplicated SAM (MUAC \<115 mm or PTZ \<-3 and / or presence of Grade + or ++ nutritional edema and moderate or good appetite with absence of medical complications)
- Signed Informed Consent
You may not qualify if:
- No Informed Consent given
- Not directly admitted for the treatment of uncomplicated SAM at the CRENAS (Center for Outpatient Nutritional Rehabilitation for Malnutrition) of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Epicentrelead
- Médecins Sans Frontières, Francecollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Rebecca GRAIS, PhD
Epicentre
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 21, 2017
First Posted
December 12, 2017
Study Start
September 1, 2016
Primary Completion
September 29, 2017
Study Completion
December 31, 2018
Last Updated
August 14, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share
The results of the study will be regularly communicated to all partners. A scientific article will be prepared and presented to the reading committee of a specialized journal, as well as to international symposia, in order to allow wide dissemination to the scientific community. MSF standard policy on data sharing will apply.